Objective: As ABCG1 plays a role in cholesterol efflux, macrophage ABCG1 expression has been suggested to protect against atherosclerosis. However, we and others observed varying effects of ABCG1 deficiency on atherosclerotic lesion size. The objective of this study was to define the effect of ABCG1 deficiency during atherosclerotic lesion progression in LDL receptor knockout (LDLr KO) mice.
Introduction
Reverse cholesterol transport (RCT), defined as the transport of excess cholesterol from peripheral tissues back to the liver for biliary excretion, plays an important protective role in the development of atherosclerosis. 1, 2 Previously, the ATPbinding cassette (ABC) transporter A1 has been reported to play an important role in the prevention of atherosclerosis by facilitating cholesterol and phospholipid efflux from macrophages to lipid-poor or lipid-free apolipoprotein A-I (apoA-I). [3] [4] [5] [6] Similar to ABCA1, ABCG1 has been implicated in macrophage lipid homeostasis by actively effluxing cellular cholesterol to mature HDL. 7, 8 As cholesterol efflux from macrophages is an important protective mechanism to prevent excessive cellular lipid accumulation, macrophage ABCG1 expression was expected to protect against atherosclerosis. However, independent groups have shown that ABCG1 might be pro-atherogenic as well as anti-atherogenic.
Previously, we reported that both total body and macrophage ABCG1 deficiency led either to a significantly increased susceptibility to atherosclerotic lesion development, 9, 10 or to no change in lesion size. 11, 12 In contrast, the group of Edwards et al. 13, 14 and Tall et al. 15 The aim of this study was to assess the effect of ABCG1 deficiency on different stages of atherosclerotic lesion development and especially during the exponential phase of lesion formation in order to unravel the mechanism by which ABCG1 deficiency affects atherogenesis. Upon atherogenic diet feeding, total body ABCG1 KO mice develop only modest atherosclerotic lesions. Therefore, we generated ABCG1/LDLr double knockout (ABCG1/LDLr dKO) mice to perform this lesion stage dependent study.
Methods
Animals ABCG1 heterozygous mice, obtained from Deltagen Inc., San Carlos, CA, USA were cross-bred with single LDLr KO mice to generated ABCG1/LDLr dKO mice on a C57BL/6J background (8 generations) .
Genotyping for ABCG1 and LDLr was performed according to the protocol from Deltagen and The Jackson Laboratory, respectively. Male ABCG1/LDLr dKO and LDLr KO mice were maintained on sterilized regular chow diet containing 4.3% (w/w) fat and no cholesterol (RM3, Special Diet Services, Witham, UK) and water ad libitum. At 10 weeks of age, the diet was switched to a high-fat, high-cholesterol Westerntype diet (WTD), containing 15% (w/w) cocoa butter and 0.25% (w/w) cholesterol (Diet W; Abdiets, Woerden, The Netherlands) to induce atherosclerotic lesion development. After 10 and 12 weeks of diet 5 feeding, mice were sacrificed after an overnight fasting period. Animal experiments were performed at the Gorlaeus Laboratories of the Leiden/Amsterdam Center for Drug Research in accordance with the National Laws. All experimental protocols were approved by the Ethics Committee for Animal Experiments of Leiden University.
Serum lipid analyses
Serum concentrations of free cholesterol were determined by enzymatic colorimetric assays with 0.048 U/mL cholesterol oxidase (Sigma) and 0.065 U/mL peroxidase (Roche Diagnostics, Mannheim, Germany) in reaction buffer (1.0 KPi buffer, pH=7.7 containing 0.01 M phenol, 1 mM 4-amino-antipyrine, 1% polyoxyethylene-9-laurylether, and 7.5% methanol). For the determination of total cholesterol, 0.03 U/ mL cholesteryl esterase (Seikagaku, Tokyo, Japan) was added to the reaction solution. Absorbance was read at 490 nm. Precipath (standardized serum; Roche Diagnostics) was used as internal standard. The distribution of cholesterol over the different lipoproteins in serum was determined by fractionation of 25 µl of serum of each mouse using a Superose 6 column (3.2 x 300 mm, Smart-System; Pharmacia, Uppsala, Sweden). Total cholesterol content of the effluent was determined as described above.
ApoE western blot
The circulating apoE levels were measured by analyzing 0.1μl of serum on a 10% SDS-page gel. ApoE was detected using a rabbit-anti-mouse apoE polyclonal antibody (Abcam) as primary antibody and goatanti-rabbit IgG (Jackson ImmunoResearch) as a secondary antibody.
Histological analysis of the aortic root and other organs
To analyze lipid accumulation in the different tissues, mice were sacrificed after 10 and 12 weeks of WTD feeding. After in situ perfusion, organs were excised and stored in 3.7% neutral-buffered formalin (Formal-fixx; Shandon Scientific Ltd, UK). Atherosclerotic lesion development was quantified in oil red-O-stained cryosections of the aortic root of LDLr KO and ABCG1/LDLr dKO mice using the Leica image analysis system, consisting of a Leica DMRE microscope coupled to a video camera and Leica Qwin Imaging software (Leica Ltd., Cambridge, UK). Mean lesion area (in µm 2 ) was calculated from ten sections at 20 μm intervals, starting at the appearance of the tricuspid valves. Sections were stained immunohistochemically for the presence of macrophages using a rat MoMa-2 antibody, dilution 1:50 (Serotec Ltd., Oxford, UK). The percentage area of the lesion that is composed of macrophages was calculated as a ratio of the macrophage-stained area and the lesion area of one heart section per mouse of 7-8 mice in total. Masson Trichrome-staining (Sigma Diagnostics, USA) was used to determine the collagen content of the plaque. Apoptotic macrophages in atherosclerotic lesions were identified by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining using the In Situ Cell Death Detection Kit (Roche Diagnostics, Mannheim, Germany). The percentage area of the lesion that is composed of necrotic core was calculated as a ratio of the necrotic-stained area (TUNELstaining positive and lack of nuclei) and the lesion area of one heart section per mouse of 7-8 mice in total. Corresponding sections of atherosclerotic lesions were stained immunohistochemically with a primary antibody specific for murine ABCA1 (Santa Cruz, Santa Cruz, CA, USA). In addition, seven μm cryosections of formalin-fixed lung and spleen from LDLr KO and ABCG1/LDLr dKO mice were prepared and stained for lipid accumulation using oil red-O staining. Hematoxylin (Sigma) was used to stain the nuclei in the different organs.
Cellular cholesterol efflux
Bone marrow cells, isolated from LDLr KO and ABCG1/LDLr dKO mice, were cultured for 7 days in complete RPMI medium supplemented with 20% fetal calf serum (FCS) and 30% L929 cell-conditioned medium, as the source of macrophage colony-stimulating factor (M-CSF), to generate bone marrow-derived macrophages. Bone marrow-derived macrophages were subsequently incubated with 0.5 µCi/mL 3 H-cholesterol in DMEM / 0.2% bovine serum albumin (BSA) for 24 hours at 37°C in 24 well tissue culture plates (Greiner Bio-One). To determine cholesterol loading, cells were washed 3 times with washing buffer (50 mmol/L Tris containing 0.9% NaCl, 1 mmol/L EDTA, and 5 mmol/L CaCl 2 , pH 7.4), lysed in 0.1 mol/L NaOH, and the radioactivity was determined by liquid scintillation counting. Cholesterol effl ux was studied by incubation of the cells with DMEM / 0.2% BSA alone or supplemented with either 10 μg/ mL apoA-I (Calbiochem) or 50 µg/mL human HDL (density 1.063 to 1.21 g/mL), isolated according to Redgrave et al. 15 Radioactivity in the medium and the cells was determined by scintillation counting after 24 hours of incubation. The cholesterol effl ux percentages are calculated as the amount of radioactivity in the medium compared to the total amount of radioactivity measured in the medium plus the cells. Basal effl ux to BSA (in the absence of added acceptors) has been subtracted from the data shown.
Statistical analysis
Statistical analyses were performed using GraphPad Instat software. The probability level (alpha) for statistical signifi cance was set at 0.05. Results are expressed as an average ± SEM.
Results

Effect of ABCG1 defi ciency on serum lipid levels and lipid homeostasis in tissues
On regular chow diet, containing 4.3% fat and no added cholesterol, no signifi cant difference in total serum cholesterol levels were observed between LDLr KO and ABCG1/LDLr dKO mice ( Table 1) . Fractionation of serum lipoproteins, however, showed a moderate shift of HDL cholesterol to the LDL and VLDL fraction in Both after 10 weeks and 12 weeks on the WTD, total serum cholesterol levels did not differ between the groups. Lipoprotein profiles of mice fed the WTD for 10 and 12 weeks were essentially identical. Therefore, the representative 12
weeks WTD profile of ABCG1/LDLr dKO and control mice on WTD is shown in Figure 1B . A moderate increase in VLDL (~25%) and LDL (~23%) cholesterol levels was observed in ABCG1/LDLr dKO mice compared to control animals, which only reached significance for LDL after 12 weeks WTD feeding (p<0.01; Table 1 ).
This increase in VLDL and LDL was associated with a moderate non-significant decrease in HDL (~16%) levels in ABCG1/LDLr dKO. Furthermore, during the course of the experiment, the weight gain curve did not show significant differences between ABCG1/LDLr dKO and LDLr KO mice both after 10 or 12 weeks on WTD (data not shown).
ABCG1 deficiency has been shown to coincide with increased secretion of apoE by macrophages and elevated serum apoE levels. 16 Immunoblotting for apoE was performed to analyse the association of ABCG1 deficiency with serum apoE levels of the LDLr KO mice fed WTD for 10 and 12 weeks. No significant effect of ABCG1 deficiency was observed on serum apoE levels between the ABCG1/LDLr dKO and LDLr KO mice fed WTD (Fig. 1B ). In addition, ABCG1 deficiency in macrophages has been shown to be correlated with an induction of ABCA1 expresssion. 15 However, immunohistochemical staining of aortic root cryosections showed no apparent increase in ABCA1 expression in macrophages located in atherosclerotic lesions of ABCG1/LDLr dKO mice, neither after 10 nor 12 weeks WTD feeding (data not shown).
Abnormal lung morphology was observed in ABCG1/LDLr dKO mice compared with control mice. Both after 10 and 12 weeks of diet feeding, ABCG1 defi ciency resulted in accumulation of large amounts of lipids in the subpleural regions of the lungs (Fig. 2 ). In addition, spleens of ABCG1/LDLr dKO showed lipid accumulation in the red pulp regions, while no accumulation was observed in spleens of control mice ( Fig. 3 ).
Effect of ABCG1 disruption on atherosclerotic lesion formation
To defi ne the role of ABCG1 in the exponential phase of atherogenesis, appeared to be attenuated from 10 till 12 weeks and only a 1.2-fold increase in lesion size is noticed over this period. As a result, ABCG1-deficient mice showed a 1.7-fold smaller atherosclerotic lesions as compared to control mice after 12
weeks WTD feeding (160±20x10 3 μm 2 (n=8) compared to 273±19x10 3 μm 2 (n=9); p<0.01, respectively; Fig. 4A ).
Disruption of ABCG1 in LDLr KO mice also affected the composition of atherosclerotic lesions. Immunostaining for macrophages showed less staining in atherosclerotic lesions of ABCG1/LDLr dKO mice fed WTD for 10 weeks (65±2% of atherosclerotic area compared with 81±4% in control mice; p<0.01; Fig. 5A ).
The lower macrophage content, coincided with an almost significantly larger percentual necrotic core area after 10 weeks on WTD (22±5% of atherosclerotic area compared with 8±3% in control mice; p=0.06). Additional 2 weeks of WTD feeding resulted in an increase in absolute macrophage area and necrotic core area ( Fig. 5A ). However, no significant differences could be observed between lesions of LDLr KO and ABCG1/LDLr dKO mice. Furthermore, Masson Trichromestaining showed no significant differences in collagen accumulation in the atherosclerotic plaques between the ABCG1-deficient mice and control mice after 10 weeks and 12 weeks of WTD feeding (data not shown). Figure 5 . Quantification of lesion macrophages and necrotic core in LDLr KO and ABCG1/LDLr dKO mice after 10 and 12 weeks of WTD feeding. The macrophage lesion area, necrotic core area and apoptotic macrophages were histochemically quantified and expressed as % area of the lesions that is composed of macrophages or necrotic core and/or expressed as absolute area (µm 2 ). *p<0.05 and **p<0.01.
As in vitro studies have recently demonstrated that macrophage ABCG1 deficiency
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is associated with increased susceptibility to apoptosis in response to the altered cellular lipid homeostasis, 13 we examined the apoptotic macrophage content of the lesions by TUNEL staining. Lesions of ABCG1-deficient mice fed the WTD for 10 weeks showed no differences in TUNEL-positive macrophages compared with lesions of control mice (Fig. 5B ). After 12 weeks of WTD feeding, a 2.5fold increase in TUNEL-positive macrophages was observed in lesions of ABCG1/ LDLr dKO mice compared with LDLr KO animals (p<0.05, n=7-8). The decrease in atherosclerotic lesion size observed in ABCG1/LDLr dKO mice fed WTD for 12 weeks, might therefore be a result of increased susceptibility to apoptosis of ABCG1-deficient macrophages inside the lesions.
Overall, these findings indicate that the effect of ABCG1 deficiency on atherosclerotic lesion development depends on the stage of atherogenesis.
ABCG1 expression protects against early atherosclerotic lesion development, by
facilitating cholesterol efflux from macrophages to HDL. In the more advanced lesions, however, accumulation of cholesterol due to impaired cholesterol efflux from ABCG1-deficient macrophages, eventually, will lead to increased macrophage apoptosis and a reduced further progression of atherogenesis.
Discussion
Several pathways are involved in the efflux of cholesterol from macrophages, including aqueous diffusion, SR-BI mediated cholesterol efflux, efflux dependent on macrophage apoE secretion, and active cholesterol efflux mediated by ABCA1. [17] [18] [19] Also ABCG1 has been implicated in cellular lipid homeostasis by its property to actively efflux cholesterol to mature HDL. 8, 20 Studies using genetically engineered mice have established the physiological importance of ABCG1.
Targeted disruption of ABCG1 in mice resulted in age-related progressive pulmonary lipidosis when fed a regular chow diet. [21] [22] [23] In addition, overexpression of ABCG1 protected against diet-induced lipid deposition within multiple tissues. 8 These findings imply a critical role for ABCG1 in maintaining normal lipid metabolism in the lung, thereby preventing inflammatory responses triggered by massive cholesterol and/or cholesterol metabolite accumulation.
Although the critical role of ABCG1 in lung lipid homeostasis is clearly established, contradictory findings on the role of macrophage ABCG1 in the development of atherosclerosis have been reported by different groups/laboratories. [9] [10] [11] [12] [13] [14] 16, [24] [25] [26] Transgenic mice overexpressing human ABCG1 showed either no effect, 25 or increased atherosclerosis. 26 In contrast, Westerterp et al. 27 recently reported an atheroprotective role of vascular ABCG1, which is likely related to its role in the preservation of endothelial NO synthase activity. Furthermore, independent studies using ABCG1-deficient mice or LDLr KO mice transplanted with bone marrow cells of ABCG1-deficient mice, have shown that macrophage ABCG1 might be proatherogenic, 9, 10, 12 as well as antiatherogenic. [13] [14] [15] In the present study, we show that ABCG1 deletion in LDLr KO mice can both induce and attenuate atherosclerotic lesion development. ABCG1 deficiency led to a significant 48% increase in atherosclerotic lesion size after only 10 wks Western-type diet feeding, while a significant 32% decrease in lesion size was observed after 12 wks WTD feeding. These data imply that the effect of ABCG1 deficiency on atherosclerotic lesion development in LDLr KO mice depends on the stage of atherogenesis.
The reduced atherosclerosis in LDLr KO mice transplanted with ABCG1 KO bone marrow was suggested to be a result of compensatory induction of apoE secretion and ABCA1 expression in ABCG1-deficient macrophages. 16 In this study, however, both at 10 weeks and 12 weeks of WTD feeding, ABCG1/LDLr dKO mice showed no compensatory increase in serum apoE levels, although ABCG1/ LDLr dKO mice did exhibit a decrease in atherosclerotic lesion development at 12 weeks of WTD feeding. These findings are in agreement with our previous studies showing that apoE mRNA and protein expressions were not affected upon deletion of ABCG1. 10, 12 In addition, no apparent increase in ABCA1 expression was observed in ABCG1-deficient macrophages in atherosclerotic lesions of LDLr KO. Furthermore, accelerated apoptosis was proposed as a mechanism for the reduced atherosclerosis susceptibility of LDLr KO mice lacking ABCG1 in macrophages. 13, 14 In agreement, in the present study, the more advanced atherosclerotic lesions of ABCG1/LDLr dKO mice fed WTD for 12 weeks were decreased in size and showed a significant increase in TUNEL-positive Figure 6 . Data from bone marrow transplantation studies in LDLr KO mice and total body studies by different groups, the present study, and unpublished studies are included (experimental details represented in Table 2 ). In early atherosclerotic lesions (lesions <167x10 3 μm 2 ), ABCG1 deficiency causes an increase in atherosclerotic lesion development (ratio>1.0), while at atherosclerotic lesion sizes above 167x10 3 μm 2 , enhanced apoptosis and/or compensatory mechanisms lead to retarded lesion progression. The numbers given in the graph represent the reference numbers of the different studies.
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feature of atherosclerotic plaque development and occurs during all stages of atherosclerosis with increasing frequencies as the plaque develops. 28 Research directed at understanding the functional consequences of macrophage death in atherosclerosis has revealed opposing roles for apoptosis in atherosclerotic plaque progression. Under normal physiologic conditions, apoptotic cells are rapidly cleared by phagocytes, a process called efferocytosis. In early atherosclerotic lesions, macrophage apoptosis, followed by efferocytosis limits lesion cellularity and suppresses plaque progression. 29, 30 In advanced lesions, efferocytosis is defective and under these conditions macrophage apoptosis thus promotes the development of the necrotic core. 31, 32 We show that lesions of ABCG1/LDLr dKO mice fed WTD for 10 weeks exhibited an increase in necrotic core in the absence of an increase in TUNEL-positive macrophages. In addition, in atherosclerotic lesions induced by 12 weeks WTD feeding, ABCG1 deficiency did not affect necrotic core size, despite a significant increase in macrophage apoptosis. These findings suggest that analysis of macrophage apoptosis is a snapshot and that there may be additional determinants of the lesional necrotic core area. Necrosis can be either secondary to apoptosis (secondary necrosis) or a primary process. 33 In particular, necrotic cores are formed by multiple processes, including accumulation of both intracellular and extracellular lipid. 34, 35 Several studies have reported that ABCG1
KO macrophages are indeed more susceptible to oxLDL-induced apoptosis as compared to ABCG1-expressing cells. 13, 14, 36 Efflux of 7-ketocholesterol, the main oxysterol present in oxLDL, is completely dependent on expression of ABCG1 and not on the expression of ABCA1. 36 Therefore, ABCG1-deficient macrophages show increased accumulation of 7-ketocholesterol upon oxLDL loading, which is cytotoxic to the cell and induces accelerated apoptosis, 14, 36 indicating that ABCG1
is essential for the prevention of oxLDL-induced apoptosis.
Our findings suggest that in addition to accelerated apoptosis, ABCG1 deficiency also leads to increased necrotic core formation. Under normal physiological conditions, necrotic core formation becomes more prominent in advanced lesions.
In absence of ABCG1, however, necrotic core formation is already evident in early atherosclerotic lesions.
The current study indicates that the effect of ABCG1 deficiency on atherosclerotic lesion size depends on the stage of lesion development. To investigate the differential effects found on atherosclerosis susceptibility upon disruption of ABCG1, correlation analysis was performed on published studies of the independent groups, the current study, and one other unpublished study of our group. Experimental details of these studies are represented in Table 2 .
Although different diets and protocols were used in the individual studies, a high correlation (R=0.92) can be found when the fold increase/decrease in atherosclerotic lesion size of ABCG1 KO mice compared to ABCG1 WT mice is plotted against the atherosclerotic lesion size of ABCG1 WT mice (Fig. 6 ). Based on this clear correlation, we propose that the effect of ABCG1 deficiency on lesion development depends on the stage of atherogenesis. In early atherosclerotic lesions (lesions <167x10 3 μm 2 ), ABCG1 deficiency causes an increase in atherosclerotic lesion development (ratio>1.0), most likely as a direct result of the impaired cholesterol efflux to HDL in ABCG1-deficient macrophages. This indicates that ABCG1 expression is protective in early atherosclerotic lesion development. Interestingly, at atherosclerotic lesion sizes above 167x10 3 μm 2 , the role of ABCG1 in atherogenesis switches from anti-atherosclerotic to proatherosclerotic. In more advanced lesions, the persistent impaired cholesterol efflux from ABCG1-deficient macrophages is likely to induce accumulation of (oxy)sterols, which leads to enhanced apoptosis/compensatory mechanisms and, subsequently, decreased atherosclerotic lesion size (ratio<1.0). Previously, we 10 also have reported a highly significant correlation when the fold increase/decrease in atherosclerotic lesion size of ABCG1 KO as compared with ABCG1 WT is plotted against total serum cholesterol whereby at about 900 mg/dL serum cholesterol a switch from ABCG1's protective function to lesion formation was noticed. When recent published studies of the independent groups, the current study, and two other unpublished studies of our group are included, again a high correlation between the fold increase/decrease in atherosclerotic lesion size and total serum cholesterol is observed with a switch at 1000 mg/dL serum cholesterol from an atheroprotective function of ABCG1 to a proatherogenic function (p=0.0075;
R=0.73). Therefore, under normal physiological levels of cholesterol, the role of ABCG1 in atherogenesis is likely to be protective. Furthermore, since higher serum cholesterol levels are associated with a more rapid development of atherosclerotic lesions, this correlation is probably also a direct effect of the stage of atherosclerotic lesion development.
In conclusion, our results indicate that the effect of ABCG1 on lesion development depends on the stage atherogenesis, whereby the absence of ABCG1 leads to increased lesions at sizes <167x10 3 μm 2 while in more advanced stages of atherosclerosis enhanced apoptosis and/or compensatory mechanisms lead to retarded lesion progression.
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